← Back to Clinical Trials
Recruiting NCT06846359

Treatment of Upper Gastrointestinal Symptoms Using Hypnotherapy Sessions

Trial Parameters

Condition GI Symptoms
Sponsor Mayo Clinic
Study Type INTERVENTIONAL
Phase N/A
Enrollment 100
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-02-20
Completion 2027-01-01
Interventions
HypnotherapyEducational module

Brief Summary

The purpose of this research is to evaluate if hypnotherapy delivered digitally will help your GI symptoms.

Eligibility Criteria

Inclusion criteria: * Patients will meet criteria for at least one upper GI DGBI including functional dyspepsia, any nausea/vomiting disorder, or functional abdominal bloating. Lower GI DGBIs, such as IBS, are allowable if the primary symptom is either an upper GI symptom or bloating/distension. * Participants will have had a negative 4-hour solid food gastric emptying test previously or a normal C13 Breath test at screening. * Patients with known disaccharide intolerances may be included if dietary restrictions are maintained during the duration of the study. * Patients utilizing cannabinoid based substances may be included if no dose changes are made during the duration of the study * Patients will be proficient in English language for comprehension of content * Patients will have reliable access to digital delivery systems for content and questionnaire access via smartphone over the course of the study and follow up period. Exclusion criteria: * Patients with known current diagnosis

Related Trials